Bausch Lomb Inc 1400 North Goodman St Rochester Ny 14609 3547 Pma Numberp980006 Supplement Numbers035 Date Received08 12 2022 Decision Date09 29 2022 Product Code Lpm Advisory Committee Ophthalmic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Bausch Lomb Inc 1400 North Goodman St Rochester Ny 14609 3547 Pma Numberp980006 Supplement Numbers035 Date Received08 12 2022 Decision Date09 29 2022 Product Code Lpm Advisory Committee Ophthalmic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P980006S035 Bausch & Lomb, Inc.1400 North Goodman St.rochester, NY 14609-3547 PMA NumberP980006 Supplement NumberS035 Date Received08/12/2022 Decision Date09/29/2022 Product Code LPM  Advisory Committee Ophthalmic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	Pure Vision (balafilcon A) Visibility Tinted Soft (hydrophilic) Contact Lenses	2022-09-29